PREVENT HIV BY

PRESCRIBING PrEP

Learn More

PrEP clinical guidelines

The 2021 ASHM PrEP Guidelines are now published online. These guidelines have been reviewed and updated by the PrEP guidelines panel and reviewed by the PrEP guidelines reviewing committee.The recommendations in these guidelines are designed to:

Support clinicians in prescribing PrEP using forms of coformulated tenofovir and emtricitabine that have been registered in Australia by the Therapeutic Goods Administration and other bioequivalent generic drugs that are available in Australia through self-importation, private prescription or Australian PrEP clinical trials.

Quick steps
to prescribe PrEP

PrEP guidelines

BROWSE TOPICS

introduction

Introduction

introduction

PrEP in Australia

introduction

Behavioural suitability
for PrEP

introduction

Clinical assessment
before starting PrEP

introduction

Providing PrEP

introduction

Monitoring patients
on PrEP

introduction

Special clinical
considerations

introduction

NPEP and PrEP

introduction

Improving adherence
and risk reduction